Suzhou Highfine Biotech Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE1000064T6
CNY
50.12
-8.03 (-13.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
447.70
386.26
444.07
366.29
279.87
190.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
447.70
386.26
444.07
366.29
279.87
190.07
Raw Material Cost
277.96
244.27
256.85
199.99
151.68
103.63
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
59.77
47.54
36.73
27.23
64.85
12.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.24
0.18
0.39
0.22
0.14
0.07
Selling and Distribution Expenses
42.49
33.90
22.76
24.57
48.62
15.80
Other Expenses
-2.90
-2.20
-1.61
-1.33
-4.29
-0.58
Total Expenditure (Excl Depreciation)
351.48
303.90
300.65
238.75
222.37
126.47
Operating Profit (PBDIT) excl Other Income
96.19999999999999
82.4
143.4
127.5
57.5
63.6
Other Income
55.69
34.62
7.01
1.91
-2.43
4.56
Operating Profit (PBDIT)
169.31
126.81
161.42
136.27
56.91
69.99
Interest
0.24
0.18
0.39
0.22
0.14
0.07
Exceptional Items
5.64
0.22
-0.29
-0.08
-0.10
-0.33
Gross Profit (PBDT)
169.74
142.00
187.22
166.30
128.19
86.43
Depreciation
20.07
14.37
11.78
6.92
2.05
2.07
Profit Before Tax
154.64
112.49
148.96
129.05
54.62
67.52
Tax
20.58
13.51
19.59
17.65
14.22
9.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
134.05
98.97
129.37
111.40
40.40
58.12
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
134.05
98.97
129.37
111.40
40.40
58.12
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
134.05
98.97
129.37
111.40
40.40
58.12
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,268.27
2,211.86
482.28
372.57
260.83
173.41
Earnings per share (EPS)
1.24
0.92
1.2
1.03
0.37
0.54
Diluted Earnings per share
1.24
0.92
1.2
1.03
0.37
0.54
Operating Profit Margin (Excl OI)
20.9%
20.15%
32.12%
34.79%
20.47%
33.34%
Gross Profit Margin
39.02%
32.84%
36.2%
37.12%
20.25%
36.61%
PAT Margin
29.94%
25.62%
29.13%
30.41%
14.44%
30.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 15.89% vs -13.02% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 35.45% vs -23.49% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 23.21% vs -40.28% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 0.00% vs -50.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Suzhou Highfine Biotech Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
447.70
0
447.70
Other Operating Income
0.00
0.00
0.00
Total Operating income
447.70
0
447.70
Raw Material Cost
277.96
0
277.96
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
59.77
0
59.77
Power Cost
0
0
0.00
Manufacturing Expenses
0.24
0
0.24
Selling and Distribution Expenses
42.49
0
42.49
Other Expenses
-2.90
0.00
-2.90
Total Expenditure (Excl Depreciation)
351.48
0
351.48
Operating Profit (PBDIT) excl Other Income
96.22
0.00
96.22
Other Income
55.69
0
55.69
Operating Profit (PBDIT)
169.31
0
169.31
Interest
0.24
0
0.24
Exceptional Items
5.64
0
5.64
Gross Profit (PBDT)
169.74
0
169.74
Depreciation
20.07
0
20.07
Profit Before Tax
154.64
0
154.64
Tax
20.58
0
20.58
Provisions and contingencies
0
0
0.00
Profit After Tax
134.05
0
134.05
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
134.05
0
134.05
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
134.05
0
134.05
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,268.27
0
2,268.27
Earnings per share (EPS)
1.24
0
1.24
Diluted Earnings per share
1.24
0
1.24
Operating Profit Margin (Excl OI)
20.90%
0%
0.00
20.90%
Gross Profit Margin
39.02%
0%
0.00
39.02%
PAT Margin
29.94%
0%
0.00
29.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 44.77 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 15.89% vs -13.02% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 13.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 35.45% vs -23.49% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.36 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 23.21% vs -40.28% in Dec 2023

Annual - Interest
Interest 0.02 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs -50.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.90%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023